高级检索
当前位置: 首页 > 详情页

Hyperthermia Improves Immune Function and Radiotherapy Efficacy in Patients with Post-Operative Recurrent Gastric Cancer

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

单位: [1]Wuhan Ctr Hosp, Dept Oncol, Wuhan, Peoples R China [2]Wuhan Ctr Hosp, Dept Gastroenterol, Wuhan, Peoples R China [3]Wuhan Ctr Hosp, Dept Gastrointestinal Surg, Wuhan, Peoples R China [4]Huazhong Univ Sci & Technol,Tongji Med Coll,Tongji Hosp,Dept Oncol,Wuhan 430030,Peoples R China [5]Huazhong Univ Sci & Technol,Tongji Med Coll,Tongji Hosp,Dept Neurosurg,Wuhan 430030,Peoples R China
出处:
ISSN:

关键词: Gastric Cancer Hyperthermia Three-Dimensional Conformal Radiation Therapy T-Lymphocyte Subset

摘要:
Background/Aims: Hyperthermia has long been used in combination with radiation for the treatment of cancers. This study aimed to investigate the efficacy, safety and impact on the immune function of the abdominal hyperthermia combining With radiotherapy. Methodology: Sixty-eight patients with post-operative local recurrent gastric carcinoma were divided randomly into two groups. Patients in 3DCRT+HT group received three-dimensional conformal radiotherapy combined with abdominal hyperthermia white patients from 3DCRT group only received the three-dimensional conformal radiation therapy. The differences of efficacy, toxicity and the Impact on immune :function between two kinds of therapies were compared. Results: Response rate in 3DCRTA-HT group Was 57.2%, which Was significant higher than that in 3DCRT group (47.1%) (P=0.04): Median local progression-free survival time of 3DCRT+HT group (14 months) was significantly longer than 3DCRT group (11 months). The peripheral blood T lymphocyte subsets analyses showed that, after the treatment, CD3+, CD4+, NK level and CD4+/CD8+ ratio increased significantly, while there was no significant alterations for those immunological parameters in 3DCRT group. Conclusion:Abdominal hyperthermia combined with three-dimensional conformal radiotherapy could gain higher response rate, prolong median local progression-free survival time and improve immune function for the-post-operative recurrent gastric-cancer.

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2013]版:
大类 | 4 区 医学
小类 | 4 区 胃肠肝病学 4 区 外科
最新[2025]版:
JCR分区:
出版当年[2012]版:
Q3 SURGERY Q4 GASTROENTEROLOGY & HEPATOLOGY
最新[2024]版:

影响因子: 最新[2024版] 最新五年平均 出版当年[2012版] 出版当年五年平均 出版前一年[2011版] 出版后一年[2013版]

第一作者:
第一作者单位: [1]Wuhan Ctr Hosp, Dept Oncol, Wuhan, Peoples R China
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:622 今日访问量:0 总访问量:452 更新日期:2025-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)